T2	mode 58 62	oral
T3	drug 84 93	ofloxacin
T4	mode 147 151	oral
T5	drug 173 186	ciprofloxacin
T6	drug 191 200	ofloxacin
T7	food 236 241	water
T8	food 256 271	feeding product
T9	population 298 319	13 healthy volunteers
T10	pharmacokinetics 400 421	maximum concentration
T11	interaction 459 466	reduced
T12	food 505 510	water
T13	interaction 539 546	reduced
T14	pharmacokinetics 559 583	relative bioavailability
T15	drug 587 600	ciprofloxacin
T16	value 602 613	72% +/- 14%
T17	drug 657 666	ofloxacin
T18	drug 766 779	ciprofloxacin
T19	drug 784 793	ofloxacin
T20	pharmacokinetics 794 804	absorption
T21	drug 810 823	ciprofloxacin
T22	pharmacokinetics 824 834	absorption
T23	interaction 839 846	reduced
T24	drug 871 880	ofloxacin
T25	pharmacokinetics 881 891	absorption
T26	pharmacokinetics 63 80	bioavailabilities
T27	drug 98 111	ciprofloxacin
T28	pharmacokinetics 152 169	bioavailabilities
T29	food 273 279	Ensure
T30	pharmacokinetics 325 364	area under the concentration time curve
T31	food 470 476	Ensure
T32	food 532 538	Ensure
#1	AnnotatorNotes T29	nom commercial nutrition entérale
#2	AnnotatorNotes T32	nom commercial nutrition entérale
#3	AnnotatorNotes T31	nom commercial nutrition entérale
A1	valence T13 Diminution
T33	value 668 680	90% +/- 8.3%
T34	food 734 740	Ensure
#4	AnnotatorNotes T34	nom commercial nutrition entérale
T35	interaction 755 765	diminished
A2	valence T35 Diminution
A3	valence T23 Diminution
A4	valence T11 Diminution
T1	mode 27 34	enteral
T36	mode 248 255	enteral
T37	food 48 54	ensure
T38	parameter 433 438	serum
R1	absorption_decrease Arg1:T34 Arg2:T18	
R2	absorption_decrease Arg1:T34 Arg2:T19	
